ENEKF yields 7.38% · JNJ yields 2.13%● Live data
📍 ENEKF pulled ahead of the other in Year 1
Combined, ENEKF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENEKF + JNJ for your $10,000?
Enea AB (publ) provides software products for telecommunication, cybersecurity, medical device, and aerospace industries worldwide. It offers 5G data management products, such as Enea Stratum Network Data Layer, Enea Unified Data Manager, Enea Digital Identity, and Enea Equipment Identity Register; and access management and policy control services, including Enea Access Manager, Enea Policy Manager, and Enea ENUM. The company also provides traffic management services comprising Enea Video Optimization, Enea DPI and Content Filtering, Enea Integra NFV Platform, Encrypted Video Management, Enea TCP Acceleration, Enea Traffic Classifier, and Enea IP Traffic Filtering; and Enea Edge, a virtualization and management platform designed for deployment on any white-box uCPE, and optimized for common uCPE networking and edge use cases, such as SD-WAN, security, IoT, and 5G. In addition, the company offers Qosmos ixEngine, a deep packet inspection software; Qosmos Probe, a network sensor for granular visibility into network activity; Aptilo SMP Venue Wi-Fi Manager; and Zero-touch Wi-Fi IoT and Cellular IoT Connectivity services. Further, it provides Enea OSE, a real-time operating system for multi-processor systems; Enea Linux, a carrier-grade Linux for networking and real-time applications; and Enea OSEck, an operating system for high-performance and memory constrained applications. Additionally, it offers Enea Netbricks, a collection of highly portable networking protocols; Enea Element High Availability, an application development framework that simplifies the design and implementation of applications; and Enea Polyhedra, a SQL database, as well as software development and training services. Enea AB (publ) was founded in 1968 and is headquartered in Kista, Sweden.
Full ENEKF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.